Literature DB >> 7165478

Negative v positive schizophrenia. Definition and validation.

N C Andreasen, S Olsen.   

Abstract

We developed criteria for dividing the schizophrenic syndrome into three subtypes: positive, negative, and mixed schizophrenia. Positive schizophrenia is characterized by prominent delusions, hallucinations, positive formal thought disorder, and persistently bizarre behavior; negative schizophrenia, by affective flattening, alogia, avolition, anhedonia, and attentional impairment. In mixed schizophrenia either both negative and positive symptoms are prominent, or neither is prominent. We explored the validity of these criteria in a variety of ways. Significant differences between the three types were noted using external validators such as premorbid adjustment, indices of cognitive dysfunction, ventricular brain ratio, and course in hospital. The correlational structure of the symptom complexes also provided further support for our approach to subtyping.

Entities:  

Mesh:

Year:  1982        PMID: 7165478     DOI: 10.1001/archpsyc.1982.04290070025006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  243 in total

1.  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

Authors:  A Abi-Dargham; J Rodenhiser; D Printz; Y Zea-Ponce; R Gil; L S Kegeles; R Weiss; T B Cooper; J J Mann; R L Van Heertum; J M Gorman; M Laruelle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 2.  Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning.

Authors:  B E Seaton; G Goldstein; D N Allen
Journal:  Neuropsychol Rev       Date:  2001-03       Impact factor: 7.444

3.  Is the Gly82Ser polymorphism in the RAGE gene relevant to schizophrenia and the personality trait psychoticism?

Authors:  Petra Suchankova; Jonas Klang; Carin Cavanna; Göran Holm; Staffan Nilsson; Erik G Jönsson; Agneta Ekman
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

4.  Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory.

Authors:  Anita J Bechtholt-Gompf; Hali V Walther; Martha A Adams; William A Carlezon; Dost Ongür; Bruce M Cohen
Journal:  Neuropsychopharmacology       Date:  2010-06-09       Impact factor: 7.853

5.  White matter volume abnormalities and associations with symptomatology in schizophrenia.

Authors:  Nikolaos Makris; Larry J Seidman; Todd Ahern; David N Kennedy; Verne S Caviness; Ming T Tsuang; Jill M Goldstein
Journal:  Psychiatry Res       Date:  2010-06-09       Impact factor: 3.222

6.  Spatio-temporal luminance contrast sensitivity and visual backward masking in schizophrenia.

Authors:  Walter L Slaghuis
Journal:  Exp Brain Res       Date:  2004-01-30       Impact factor: 1.972

7.  Family management of schizophrenia: a comparison of behavioral and supportive family treatment.

Authors:  T R Zastowny; A F Lehman; R E Cole; C Kane
Journal:  Psychiatr Q       Date:  1992

8.  System impact and methodological issues in the development of an empirical typology of psychiatric hospital residents.

Authors:  E J Holohean; S M Banks; B A Maddy
Journal:  J Ment Health Adm       Date:  1995

Review 9.  Negative symptoms: psychopathological models.

Authors:  J Ananth; A Djenderdjian; P Shamasunder; J Costa; J Herrera; J Sramek
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

10.  Positive and negative symptoms in families with schizophrenia.

Authors:  A S Bassett; E J Collins; S E Nuttall; W G Honer
Journal:  Schizophr Res       Date:  1993-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.